Connection

David Cole to Humans

This is a "connection" page, showing publications David Cole has written about Humans.
Connection Strength

0.472
  1. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017 04 07; 10(1):82.
    View in: PubMed
    Score: 0.022
  2. Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8+ T-cell response. J Immunotoxicol. 2016 11; 13(6):784-792.
    View in: PubMed
    Score: 0.021
  3. Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells. Cancer Immunol Immunother. 2015 May; 64(5):539-49.
    View in: PubMed
    Score: 0.019
  4. Soluble IL-15/IL-15Ra complexes in human serum. Blood. 2012 Jul 05; 120(1):1-2.
    View in: PubMed
    Score: 0.016
  5. Bias-free identification of a linear model-predictive steering controller from measured driver steering behavior. IEEE Trans Syst Man Cybern B Cybern. 2012 Apr; 42(2):434-43.
    View in: PubMed
    Score: 0.015
  6. Perioperative normothermia during major surgery: is it important? Adv Surg. 2011; 45:249-63.
    View in: PubMed
    Score: 0.014
  7. Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination. Cancer Immunol Immunother. 2010 Mar; 59(3):341-53.
    View in: PubMed
    Score: 0.013
  8. Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer. 2008 Feb 20; 8:55.
    View in: PubMed
    Score: 0.012
  9. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
    View in: PubMed
    Score: 0.011
  10. Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity. J Interferon Cytokine Res. 2006 Sep; 26(9):593-608.
    View in: PubMed
    Score: 0.010
  11. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
    View in: PubMed
    Score: 0.009
  12. The molecular detection of micrometastatic breast cancer. Am J Surg. 2003 Oct; 186(4):351-8.
    View in: PubMed
    Score: 0.009
  13. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer. Anticancer Res. 2003 May-Jun; 23(3A):2007-13.
    View in: PubMed
    Score: 0.008
  14. Society of University Surgeons statement on surgical resident work hours and education. Surgery. 2002 Aug; 132(2):115-8.
    View in: PubMed
    Score: 0.008
  15. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001 Jul 15; 93(2):162-71.
    View in: PubMed
    Score: 0.007
  16. Prognostic factors for residual occult disease in shave margins during partial mastectomy. Breast Cancer Res Treat. 2021 Sep; 189(2):471-481.
    View in: PubMed
    Score: 0.007
  17. A Multifaceted Approach to Opioid Education, Prescribing, and Disposal for Patients with Breast Cancer Undergoing Surgery. J Surg Res. 2021 01; 257:597-604.
    View in: PubMed
    Score: 0.007
  18. A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent. Surgery. 1999 Sep; 126(3):510-7.
    View in: PubMed
    Score: 0.006
  19. Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours. Cancer Treat Rev. 2019 Jul; 77:35-43.
    View in: PubMed
    Score: 0.006
  20. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg. 1998 Jul; 187(1):9-16.
    View in: PubMed
    Score: 0.006
  21. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg. 1998 Jun; 64(6):539-43; discussion 543-4.
    View in: PubMed
    Score: 0.006
  22. The South Carolina Surgical Quality Collaborative: A New Effort to Improve Surgical Outcomes in South Carolina. Am Surg. 2018 Jun 01; 84(6):916-919.
    View in: PubMed
    Score: 0.006
  23. Intrathoracic aberrant thyroid: identification critical for appropriate operative approach. Am Surg. 1998 Apr; 64(4):360-2.
    View in: PubMed
    Score: 0.006
  24. IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 02; 38(2):45-68.
    View in: PubMed
    Score: 0.006
  25. Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection. J Virol. 2018 02 15; 92(4).
    View in: PubMed
    Score: 0.006
  26. Stereotactic core biopsy of the breast: results of one-year follow-up of 101 patients. Am Surg. 1997 Dec; 63(12):1124-7.
    View in: PubMed
    Score: 0.006
  27. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cancer Res. 1997 Dec 01; 57(23):5320-7.
    View in: PubMed
    Score: 0.006
  28. Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix. Clin Cancer Res. 1997 Jun; 3(6):867-73.
    View in: PubMed
    Score: 0.006
  29. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection. Semin Oncol. 1996 Dec; 23(6):719-24.
    View in: PubMed
    Score: 0.005
  30. Melanoma-associated tumor antigens and their clinical relevance to immunotherapy. Semin Oncol. 1996 Dec; 23(6):754-8.
    View in: PubMed
    Score: 0.005
  31. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Res. 2016 09 15; 76(18):5229-5240.
    View in: PubMed
    Score: 0.005
  32. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther. 1996 Jul 10; 7(11):1381-94.
    View in: PubMed
    Score: 0.005
  33. A review of human sensory dynamics for application to models of driver steering and speed control. Biol Cybern. 2016 06; 110(2-3):91-116.
    View in: PubMed
    Score: 0.005
  34. Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Ra Dependent. Cancer Immunol Res. 2015 Dec; 3(12):1364-74.
    View in: PubMed
    Score: 0.005
  35. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. J Control Release. 2015 Oct 28; 216:103-10.
    View in: PubMed
    Score: 0.005
  36. IL-12 conditioning improves retrovirally mediated transduction efficiency of CD8+ T cells. Cancer Gene Ther. 2015 Jul; 22(7):360-7.
    View in: PubMed
    Score: 0.005
  37. The impact of surgical diversion before neoadjuvant therapy for rectal cancer. Am Surg. 2015 May; 81(5):444-9.
    View in: PubMed
    Score: 0.005
  38. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling. Clin Cancer Res. 2015 Jun 01; 21(11):2546-57.
    View in: PubMed
    Score: 0.005
  39. Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen. Cancer Res. 1995 Feb 15; 55(4):748-52.
    View in: PubMed
    Score: 0.005
  40. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res. 1994 Oct 15; 54(20):5265-8.
    View in: PubMed
    Score: 0.005
  41. Postoperative complications in patients receiving suramin therapy. Surgery. 1994 Jul; 116(1):90-5.
    View in: PubMed
    Score: 0.005
  42. Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes. Cancer Immunol Immunother. 1994 May; 38(5):299-303.
    View in: PubMed
    Score: 0.004
  43. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
    View in: PubMed
    Score: 0.004
  44. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors. J Control Release. 2014 Mar 28; 178:79-85.
    View in: PubMed
    Score: 0.004
  45. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 05; 86(1):39-45.
    View in: PubMed
    Score: 0.004
  46. Activity of drug-loaded tumor-penetrating microparticles in peritoneal pancreatic tumors. Curr Cancer Drug Targets. 2014; 14(1):70-8.
    View in: PubMed
    Score: 0.004
  47. A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg. 2013 Dec; 258(6):879-86.
    View in: PubMed
    Score: 0.004
  48. G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses. J Hematol Oncol. 2013 Oct 01; 6:75.
    View in: PubMed
    Score: 0.004
  49. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013 Sep; 206(3):289-95.
    View in: PubMed
    Score: 0.004
  50. A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice. J Immunol. 2012 Aug 15; 189(4):1627-38.
    View in: PubMed
    Score: 0.004
  51. Melanoma of the external ear. J Surg Oncol. 1992 Jun; 50(2):110-4.
    View in: PubMed
    Score: 0.004
  52. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012 Oct; 204(4):428-33.
    View in: PubMed
    Score: 0.004
  53. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer. 1992 May; 65(5):783-5.
    View in: PubMed
    Score: 0.004
  54. CD8(+) T cells sabotage their own memory potential through IFN-?-dependent modification of the IL-12/IL-15 receptor a axis on dendritic cells. J Immunol. 2012 Apr 15; 188(8):3639-47.
    View in: PubMed
    Score: 0.004
  55. Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg. 1992 Feb; 58(2):88-91.
    View in: PubMed
    Score: 0.004
  56. Normothermia to prevent surgical site infections after gastrointestinal surgery: holy grail or false idol? Ann Surg. 2010 Oct; 252(4):696-704.
    View in: PubMed
    Score: 0.003
  57. Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination. Anticancer Res. 2010 Oct; 30(10):3889-94.
    View in: PubMed
    Score: 0.003
  58. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:312-20.
    View in: PubMed
    Score: 0.003
  59. Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
    View in: PubMed
    Score: 0.003
  60. A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes. J Mol Diagn. 2009 Nov; 11(6):576-82.
    View in: PubMed
    Score: 0.003
  61. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
    View in: PubMed
    Score: 0.003
  62. The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer. Int J Oncol. 2008 Sep; 33(3):579-84.
    View in: PubMed
    Score: 0.003
  63. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009 Jan; 58(1):49-59.
    View in: PubMed
    Score: 0.003
  64. CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes. Am J Respir Cell Mol Biol. 2008 Jun; 38(6):671-8.
    View in: PubMed
    Score: 0.003
  65. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer. 2007 Apr 01; 120(7):1511-7.
    View in: PubMed
    Score: 0.003
  66. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg. 2006 Mar; 243(3):389-98.
    View in: PubMed
    Score: 0.003
  67. A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of colorectal carcinoma. Clin Colorectal Cancer. 2006 Jan; 5(5):368-71.
    View in: PubMed
    Score: 0.003
  68. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005 Sep; 138(3):474-81.
    View in: PubMed
    Score: 0.002
  69. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability. Cancer Res. 2005 Jul 15; 65(14):6228-36.
    View in: PubMed
    Score: 0.002
  70. An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res. 2005 May 15; 11(10):3697-704.
    View in: PubMed
    Score: 0.002
  71. Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res. 2005 Mar 15; 11(6):2205-14.
    View in: PubMed
    Score: 0.002
  72. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest. 2005 Feb; 127(2):430-7.
    View in: PubMed
    Score: 0.002
  73. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004 Aug 15; 64(16):5818-24.
    View in: PubMed
    Score: 0.002
  74. Enhanced detection of RNA from paraffin-embedded tissue using a panel of truncated gene-specific primers for reverse transcription. Biotechniques. 2004 Mar; 36(3):474-8.
    View in: PubMed
    Score: 0.002
  75. Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn. 2003 Nov; 5(4):237-42.
    View in: PubMed
    Score: 0.002
  76. Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res. 2003 Oct 15; 9(13):4865-71.
    View in: PubMed
    Score: 0.002
  77. CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell. J Immunol. 2003 Mar 01; 170(5):2582-9.
    View in: PubMed
    Score: 0.002
  78. Real-time reverse transcription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patients with non-small cell lung cancer. Clin Chem. 2003 Feb; 49(2):312-5.
    View in: PubMed
    Score: 0.002
  79. Factors influencing choice between mastectomy and lumpectomy for women in the Carolinas. J Surg Oncol. 2001 Jan; 76(1):6-12.
    View in: PubMed
    Score: 0.002
  80. Melanoma thickness and histology predict sentinel lymph node status. Am J Surg. 2001 Jan; 181(1):8-11.
    View in: PubMed
    Score: 0.002
  81. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
    View in: PubMed
    Score: 0.002
  82. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. Br J Cancer. 1999 Nov; 81(6):1002-8.
    View in: PubMed
    Score: 0.002
  83. Trends in indications and outcomes in the Whipple procedure over a 40-year period. Am Surg. 1999 Sep; 65(9):889-93.
    View in: PubMed
    Score: 0.002
  84. Magnetic resonance cholangiopancreatography: a novel approach to the evaluation of suspected pancreaticobiliary neoplasms. Ann Surg Oncol. 1997 Dec; 4(8):634-8.
    View in: PubMed
    Score: 0.001
  85. Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound. Ann Surg Oncol. 1997 Dec; 4(8):639-43.
    View in: PubMed
    Score: 0.001
  86. Identification of a T-cell receptor from a therapeutic murine T-cell clone. J Immunother. 1997 Jul; 20(4):247-55.
    View in: PubMed
    Score: 0.001
  87. Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine. 1996 Jan; 8(1):42-8.
    View in: PubMed
    Score: 0.001
  88. Combined surgery and radiotherapy for conservative management of soft tissue sarcomas. Recent Results Cancer Res. 1995; 138:47-55.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.